Involvement of cAMP and β-adrenoceptors in the relaxing effect elicited by flavonoids on rat uterine smooth muscle

Journal of Autonomic Pharmacology

Volumn 19, Issue 6, 1999, Pages 353-358

  Revuelta, M P ^a   Hidalgo, A ^a   Cantabrana, B ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; ATENOLOL; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; FLAVONOID; GENISTEIN; KAEMPFEROL; PAPAVERINE; PHOSPHODIESTERASE; POTASSIUM CHLORIDE; PROPRANOLOL; PROTEIN KINASE INHIBITOR; QUERCETIN;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; FEMALE; MYOMETRIUM; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION;

EID: 0033306581     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2680.1999.tb00008.x     Document Type: Article

References (36)

1. ADLERCREUTZ, H., MOUSAVI, Y., CLARK, J., HÖCKERSTEDT, K., HÄMÄLÄINEN, F., WÄHÄLÄ, K., MÄKELA, T. & HASE, T. (1992). Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Molec. Biol., 41, 331-337.
2. ADLERCREUTZ, H., VAN DER WILDT, J., KINZEL, J., ATTALLA, H., WÄHÄLÄ, K., MÄKELA, T., HASE, T. & FOTSIS, T. (1995). Lignan and isoflavonoid conjugates in human urine. J. Steroid Biochem. Molec. Biol., 52, 97-103.
3. ALARCÓN DE LA LASTRA, C., MARTÍN, M. J. & MOTILVA, V. (1994). Antiulcer and gastroprotective effects of quercetin: a gross and histologic study. Pharmacology, 48, 56-62.
4. BRONNER, C. & LANDRY, Y. (1985). Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions, 16, 147-151.
5. CANDENAS, M.L., ARTECHE, E., NORTE, M., ADVENIER, C. & MARTIN, J.D. (1994). Influence of calcium on the effects of okadaic acid and its interaction with caffeine and theophylline in rat myometrium. Naunyn Schmiedebergs Arch. Pharmacol., 350, 315-321.
6. CANTABRANA, B., VELASCO, G., ANDRES-TRELLES, F. & HIDALGO, A. (1989). Mechanism of nafazatrom-induced inhibition of rat uterus contractions in vitro. Arch. Int. Pharmacodyn. Ther., 301, 285-298.
7. DI SALVO, J., STEUSLOFF, A., SEMENCHUK, L., KOLQUIST, K. & PFITZER, G. (1993). Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem. Biophys. Res. Comm., 190, 968-974.
8. DUARTE, J., PÉREZ-VIZCAINO, F., UTRILLA, P., JIMÉNEZ, J., TAMARGO, J. & ZARZUELO, A. (1993). Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol., 24, 862-867.
9. FERNANDEZ, A.I., MARTINEZ, V., CANTABRANA, B. & HIDALGO, A. (1992). Differential effect of calcium and Bay k 8644 on the inhibitory action of estrogens in the rat uterus. Gen. Pharmacol., 23, 549-554.
10. FERRELL, J.E., SING, P.D.C., LOFW, G., KING, R., MANSOUR, J.M. & MANSOUR, T.E. (1979). Structure/activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices. Molec. Pharmacol., 16, 556-568.
11. FERRIOLA, P.C., CODY, V. & MIDDLETON, E. JR. (1989). Protein kinase C inhibition by flavonoids. Kinetic mechanisms and structure-activity relationship. Biochem. Pharmacol., 38, 1617-1624.
12. GODFRAIND, T. (1994). Calcium antagonists and vasodilatation. Pharmacol. Ther., 64, 37-75.
13. HERRERA, M.D., MARHUENDA, E. & GIBSON, A. (1992). Effects of genistein, an isoflavone isolated from genista tridentata, on isolated guinea-pig ileum and guinea-pig ileal myenteric plexus. Planta Med., 58, 314-316.
14. HODNICK, W.F. & PARDINI, R.S. (1998). Inhibition of mitochondrial function by flavonoids. In: Flavonoids in Health and Disease, pp. 179-198. Eds. C.A. Rice-Evans & L. Packer. New York: Marcel Decker.
15. HOLLENBERG, M.D. (1994). Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci., 15, 108-114.
16. JACKSON, W.F. (1996). Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries. Pharmacology, 52, 226-234.
17. KARAKI, H. & WEISS, G.B. (1988). Calcium release in smooth muscle. Life Sci., 42, 111-122.
18. KUIPER, G.G., LEMMEN, J.G., CARLSSON, B., CORTON, J.C., SAFE, S.H., VAN DER SAAG, P.T., VAN DER BURG, B. & GUSTAFSSON, J.A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263.
19. KUPPUSAMY, U.R. & DAS, N.P. (1994). Potentiation of β-adrenoceptor agonist-mediated lipolysis by quercetin and fisetin in isolated rat adipocytes. Biochem. Pharmacol., 47, 521-529.
20. LANDOLFI, R., MOWER, R.L. & STEINFR, M. (1984). Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem. Pharmacol., 33, 1525-1530.
21. LEROY, M.J., CEDRIN, I., BREUILLFR, M., GIOVAGRANDI, Y. & FERRE, F.R. (1989). Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term. Biochem. Pharmacol., 38, 9-15.
22. MARKAVERICH, B.M., ROBERTS, R.R., ALEJANDRO, M.A., JOHNSON, G.A., MIDDLEDITCH, B.S. & CLARK, J.H. (1988). Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J. Steroid Biochem., 30, 71-78.
23. MIDDLETON, E. JR. (1998). Effect of plant flavonoids on immune and inflammatory cell function. Adv. Exp. Med. Biol., 439, 175-182.
24. MIDDLETON, E. JR. & KANDASWAMI, C. (1992). Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol., 43, 1167-1179.
25. MURRAY, K.J. (1990). Cyclic AMP and mechanism of vasodilatation. Pharmacol. Ther., 47, 329-345.
26. NISHINO, H., NAITOH, E., IWASHIMA, A. & UMEZAWA, K. (1984). Quercetin interacts with calmodulin, a calcium regulatory protein. Experientia, 40, 184-185.
27. ORTMANN, R., NUTTO, D. & WALDMEYER, J. (1979). Phloretin and related compounds inhibit agonist stimulated cAMP accumulation in cultured cells of CNS origin. Biochem. Pharmacol., 28, 2357-2361.
28. PEREZ-VALLINA, J.R., REVUELTA, M.P., CANTABRANA, B. & HIDALGO, A. (1997). Effect of Rp diastereoisomer of adenosine 3′,5′-cyclic-monophosphothioate on the cAMP-dependent relaxation of smooth muscle. Life Sci., 61, 869-880.
29. 2. Gen. Pharmacol., 29, 847-857.
30. RODRÍGUEZ, J., GARCIA DE BOTO, M.J. & HIDALGO, A. (1996). Mechanisms involved in the relaxant effect of estrogens on rat aorta strips. Life Sci., 58, 607-615.
31. RUCKSTUHL, M. & LANDRY, Y. (1981). Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterase by flavonoids and other chromone-like compounds. Biochem. Pharmacol., 30, 697-702.
32. SALAICES, M., DE GREGORIO, A. & MARTÍN, J. (1985). Study of vasodilator effects of papaverine, adenosine and related drugs in isolated cat cerebral arteries. Gen. Pharmacol., 16, 633-636.
33. SCAMBIA, G., RANELLETTI, F.O., PACINI, P.B., PIANTELLI., M., BONANNO, G., VINCENZO, R.D.F., FFRRANDINA, G., PIERELLI, L., CAPELLI, A. & MANCUSO, S. (1991). Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother. Pharmacol., 28, 255-258.
34. WHITTFN, P.L. & NAFTOLIN, F. (1991). Dietary estrogens: a biologically active background for estrogen action. In: The New Biology of Steroid Hormones, pp. 155-167. Eds. R.B. Hochberg & F. Naftolin. New York: Raven Press.
35. WRAY, S. (1993). Uterine contraction and physiological mechanisms of modulation. Am. J. Physiol., 264, C1-C18.
36. YANG, S.G., SAIFEDDINE, M. & HOLLENBERG, M.D. (1992). Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle. Can. J. Physiol. Pharmacol., 70, 85-93.